These results suggested that miR-137 suppresses the translational activity of the Del-1 gene by targeting the binding site in the 3′-UTR of Del-1 mRNA, thereby affecting Del-1 secretion from the breast cancer cells. Here, EDIL3 is linked to breast carcinoma.